Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors
Conditions: Locally Advanced Malignant Solid Neoplasm; Metastatic Malignant Solid Neoplasm; Progressive Disease Interventions: Drug: Capecitabine; Drug: Carboplatin; Biological: Durvalumab; Drug: Gemcitabine; Drug: Gemcitabine Hydrochloride; Drug: Nab-paclitaxel; Drug: Paclitaxel; Drug: Pegylated Liposomal Doxorubicin Hydrochloride Sponsor: National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials